ProPhase Labs Inc. (NASDAQ:PRPH) posted its quarterly earnings data on Monday. The company reported $0.01 earnings per share for the quarter. The business had revenue of $5.20 million for the quarter, compared to analysts’ expectations of $4.40 million. ProPhase Labs had a negative return on equity of 38.13% and a negative net margin of 15.01%.

Shares of ProPhase Labs (NASDAQ:PRPH) opened at 2.0354 on Monday. The stock has a 50 day moving average price of $2.02 and a 200-day moving average price of $1.66. ProPhase Labs has a 12 month low of $1.05 and a 12 month high of $2.24. The company’s market capitalization is $34.76 million.

Earnings History for ProPhase Labs (NASDAQ:PRPH)

About ProPhase Labs

ProPhase Labs, Inc is a manufacturer, marketer and distributor of a range of homeopathic and health products. The Company is also engaged in the research and development of over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. It is engaged in manufacturing, distributing, marketing and sale of OTC cold remedy products to consumers through national chain, regional, specialty and local retail stores.

5 Day Chart for NASDAQ:PRPH

Receive News & Stock Ratings for ProPhase Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs Inc. and related stocks with our FREE daily email newsletter.